Journals / Anadolu Tıp Dergisi / 2000 / Cilt: 2 - Sayı: 3

Retrospective analysis of clinical and laboratory findings in brucellosis

Bruselloziste klinik ve laboratuvar bulgularının retrospektif olarak değerlendirilmesi

Pages
195–199
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Before the treatment, thrombocytopenia was significantly higher in the patients who had lower brucella agglutinin liter and higher erythrocyte sedimentation rate (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, clinical and laboratory findings of 130 patients, who were diagnosed and followed-up for brucellosis in an infectious diseases clinic, were retrospectively evaluated.
📊
Key Findings & Data:There were, anemia in 31.5%, leukocytosis in 9.2%, lymphocytosis in 5.4%, leukopenia in 30.7%, neutropenia in 7.7%, thrombocytopenia in 18.5%, the high erythrocyte sedimentation rate in 63.8%, hepatomegaly in 54.6%, splenomegaly in 30.8%, proteinuria in 34.6% and microscopic hematuria in 22.3% of the patients.
💡
Conclusion & Impact:Before the treatment, thrombocytopenia was significantly higher in the patients who had lower brucella agglutinin liter and higher erythrocyte sedimentation rate (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, clinical and laboratory findings of 130 patients, who were diagnosed and followed-up for brucellosis in an infectious diseases clinic, were retrospectively evaluated. Hematologic tests, in addition to clinical findings and laboratory examinations, were done before the initiation of the treatment in all of the patients. There were, anemia in 31.5%, leukocytosis in 9.2%, lymphocytosis in 5.4%, leukopenia in 30.7%, neutropenia in 7.7%, thrombocytopenia in 18.5%, the high erythrocyte sedimentation rate in 63.8%, hepatomegaly in 54.6%, splenomegaly in 30.8%, proteinuria in 34.6% and microscopic hematuria in 22.3% of the patients. Before the treatment, thrombocytopenia was significantly higher in the patients who had lower brucella agglutinin liter and higher erythrocyte sedimentation rate (p

Özet

Bu çalışmada klinikte takip edilen ve bruselloz tanısı alan 130 olgu retrospektif olarak incelenmiştir. Olgular tedavi öncesi klinik ve laboratuvar bulguları ile birlikte özellikle hematolojik olarak değerlendirilmiştir. Olguların %31.5'inde anemi, %9.2'sinde lökositoz, %5.4'ünde lenfositoz, %7.7'sinde nötropeni, %18.5'inde trombositopeni, %63.8'sinde eritrosit sedimantasyon yüksekliği, %54.6'sında hepatomegali, %30.8'inde splenomegali, %34.6'sında proteinüri ve %22.3'ünde mikroskobik hematüri saptanmıştır. Tedavi öncesi sedimantasyonu yüksek ve brusella antikor titrasyonu düşük olan olgularda trombositopeni daha yüksek oranda bulunmuştur (p

🔖

Cite This Article

BOZKURT, A. İ., SIRMATEL, F., TÜRKER, D. M. (2022). Retrospective analysis of clinical and laboratory findings in brucellosis. Anadolu Tıp Dergisi, Cilt: 2 - Sayı: 3, 195–199. https://ajindex.com/articles/438191

References (1)

  1. Akdoğan M, Karter Y, Soysal T ve ark. İmmun trombositopeni ile seyreden bir bruselloz olgusu Klinik Gelişim 1996; 9:4236-39 2. Bozkurt Aİ, Gaziantep il merkezinde ki sağlık düzeyi, Doktora tezi, Sivas 1994. 3. Castanedea RM, Guerrero G. Studies on the leucocyte picture in brucellosis JID 1986;78:45-48 4. Crosby E, Liousa L. Miroqueea M et al. Hematologic changes in human brucellosis, J Infect Dis 1984; 150(3): 419-24 5. Çolak H. Brucellosis clinical and laboratory findings and treatment in 40 patients. Microbiol Bui 1987; 21(2): 110-116 6. Garcia P, Yrivarran JL, Argumans C et al.Evaluation e la medula osea en pacientes con brucellosis. Correlacion clinicopalologica. Rev Esp Enferm Infect Microbiol Clin 1990; 8(1): 19-24 7. Gotuzzo E, Carrillo C. Brucella. In Gorbach SL,Barlett JG, Blacklow NR. Infectious Diseases (second ed), WB Saunders Company,Phyladelphia 1998, p. 1837-43 8. Göktaş P, Tosyalı T. Brusellozda hematolojik değişiklikler ve pansitopeni olguları Ege Tıp Dergisi 1990; 29(4):949-51 9. Lynch EC, MCKechnie JC, Alfrey CPJr. Brucellosis with pancitonia. Ann Intern Med 1968; 69:319-24 10. Marei HA, Shayip MA.Pancitopenia and otherhematological findings in brucellosis Scand J Hematol 1986; 36:335-38 11. McGaraty WC, Serafin D. Brucellosis, indications for splenectomy Am J Surg 1968;115:355-60 12. Moreno E, Berman DT. Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin resistant C3H/Hej mice Jour Immun 1979; 123: 2915-19 13. Wintrobe MM, Lee GK, Boggs D et al. In Clinical Hematology 7th. Ed Philadelphia Lea and Febiger 1974 14. Young EJ. Brucella species. In. Mandell, Douglas, Bennets, Principles and Practice of Infectious Diseases (4th. Ed) Churchill Livingstoine New York 1995, p.2053-60 15. Zuazu JP, Duran JW, Julia AF. Hemofagocitosis en brucellosis aguda. Rev Clin Esp 1981; 152:231-35